Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD
Open Access
- 30 May 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 890332
Abstract
Purpose: To examine the association of serum Ism1, a new adipokine that can regulate glucose uptake, with type 2 diabetes (T2D) in a Chinese population. Considering high prevalence of Nonalcoholic Fatty Liver Disease in patients with type 2 diabetes and the regulating role of Ism1 on glucose uptake of peripheral tissues, we further explored the association between Ism1 and diabetes-associated nonalcoholic fatty liver disease.Methods: A total of 120 newly diagnosed T2D patients and 60 control subjects with normal glucose were recruited in the case-control study. Serum Ism1 concentrations were determined by ELISA. Multivariate logistic regression analysis was used to evaluate the independent association of serum Ism1 concentration with the risk of T2D. The 120 newly diagnosed T2D patients were divided into uncomplicated T2D group and diabetes-associated NAFLD group according to the FLI score.Results: The Ism1 level of normoglycemic controls was higher than that of T2D patients (3.91 ± 0.24 ng/ml vs 3.01 ± 0.16 ng/ml, P=0.001). Based on quartile analysis of Ism1 level, the proportion of high circulating Ism1 levels in the control group increased while T2D group decreased, and the distribution difference was statistically significant (P=0.015). Logistic regression analysis indicated that the serum Ism1 level was an independent protective factor of type 2 diabetes (OR=0.69, 95%CI: 0.54-0.89). The decrease of Ism1 level did not increase the risk of non-alcoholic fatty liver disease in diabetic patients by Binary logistic regression analysis (OR=1.08, 95% CI: 0.69-1.69).Conclusions: The increase of serum Ism1 was associated with a decreased risk of diabetes, and it did not reduce the risk of non-alcoholic fatty liver disease in diabetic patients.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFC2701903)
This publication has 37 references indexed in Scilit:
- From leptin to other adipokines in health and disease: Facts and expectations at the beginning of the 21st centuryMetabolism, 2015
- Isthmin 1 Is a Secreted Protein Expressed in Skin, Mucosal Tissues, and NK, NKT, and Th17 CellsJournal of Interferon & Cytokine Research, 2014
- Distinct spatiotemporal expression ofISM1during mouse and chick developmentCell Cycle, 2014
- Obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: Role of adipokinesJournal of Diabetes Investigation, 2013
- Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitusExperimental and Therapeutic Medicine, 2012
- Attitudes Toward Diabetes Affect Maintenance of Drug-Free Remission in Patients With Newly Diagnosed Type 2 Diabetes After Short-Term Continuous Subcutaneous Insulin Infusion TreatmentDiabetes Care, 2012
- Leptin and Soluble Leptin Receptor Levels in Plasma and Risk of Type 2 Diabetes in U.S. WomenDiabetes, 2009
- Adiponectin Levels and Risk of Type 2 DiabetesJAMA, 2009
- Leptin Predicts Diabetes but Not Cardiovascular DiseaseDiabetes Care, 2009
- Leptin predicts the development of diabetes in Mauritian men, but not women: a population–based studyInternational Journal of Obesity, 2007